Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
$0.18
$0.97
$0.55
$21.45
$5.85M0.055.86 million shsN/A
PureTech Health plc stock logo
PRTC
PureTech Health
$17.42
-4.3%
$17.21
$13.30
$32.98
$418.29M1.144,706 shs4,294 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
0.00%0.00%0.00%0.00%0.00%
PureTech Health plc stock logo
PRTC
PureTech Health
-4.31%-0.03%+0.90%-6.27%-40.46%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
PureTech Health plc stock logo
PRTC
PureTech Health
2.1128 of 5 stars
3.84.00.00.02.40.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
0.00
N/AN/AN/A
PureTech Health plc stock logo
PRTC
PureTech Health
3.50
Strong Buy$45.00158.40% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
$20.05M0.29N/AN/A$0.17 per share1.06
PureTech Health plc stock logo
PRTC
PureTech Health
$4.32M96.94N/AN/A$16.94 per share1.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
-$161.39MN/A0.00N/A-583.38%-8,361.74%-181.35%N/A
PureTech Health plc stock logo
PRTC
PureTech Health
-$65.70MN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
N/AN/AN/AN/AN/A
PureTech Health plc stock logo
PRTC
PureTech Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
N/A
2.29
2.29
PureTech Health plc stock logo
PRTC
PureTech Health
N/A
3.68
N/A

Institutional Ownership

CompanyInstitutional Ownership
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
8.10%
PureTech Health plc stock logo
PRTC
PureTech Health
0.04%

Insider Ownership

CompanyInsider Ownership
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
39.30%
PureTech Health plc stock logo
PRTC
PureTech Health
5.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Virtual Cloud Technologies, Inc. stock logo
AVCT
American Virtual Cloud Technologies
31632.47 million19.71 millionNot Optionable
PureTech Health plc stock logo
PRTC
PureTech Health
10024.02 million22.67 millionNot Optionable

Recent News About These Companies

Leerink Partners Keeps Their Buy Rating on PureTech Health (PRTC)
Trend Tracker for (PRTC)
PureTech Health Plc (NASDAQ: PRTC)

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Virtual Cloud Technologies stock logo

American Virtual Cloud Technologies NASDAQ:AVCT

American Virtual Cloud Technologies, Inc. engages in the provision of technological solutions. Its products include network communications, data storage, desktops and servers. It operates through the Computex and Kandy segments. The Computex segment provides technology solutions through its extensive hardware, software, and value-added service offerings. The Kandy segment is a provider of cloud-based enterprise services that deploys a carrier grade proprietary cloud communication platform that supports UCaaS, CPaaS, and CCaaS for mid-market and enterprise customers across a proprietary scalable cloud platform. The company was founded on April 7, 2016 and is headquartered in Atlanta, GA.

PureTech Health stock logo

PureTech Health NASDAQ:PRTC

$17.42 -0.79 (-4.31%)
As of 05/27/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.